News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,196 Results
Type
Article (41238)
Company Profile (288)
Press Release (655670)
Section
Business (206253)
Career Advice (2121)
Deals (36101)
Drug Delivery (92)
Drug Development (81628)
Employer Resources (169)
FDA (16237)
Job Trends (15074)
News (349276)
Policy (33443)
Tag
Academia (2645)
Alliances (49605)
Alzheimer's disease (1243)
Approvals (16165)
Artificial intelligence (133)
Bankruptcy (355)
Best Places to Work (11734)
Biotechnology (205)
Breast cancer (121)
Cancer (1091)
Cardiovascular disease (98)
Career advice (1761)
Cell therapy (234)
Clinical research (64760)
Collaboration (391)
Compensation (197)
COVID-19 (2627)
C-suite (98)
Data (1124)
Diabetes (155)
Diagnostics (6233)
Earnings (85383)
Employer resources (147)
Events (111287)
Executive appointments (310)
FDA (16775)
Funding (352)
Gene therapy (178)
GLP-1 (594)
Government (4603)
Healthcare (19108)
Infectious disease (2715)
Inflammatory bowel disease (107)
Interviews (322)
IPO (16854)
Job creations (3700)
Job search strategy (1513)
Layoffs (420)
Legal (8094)
Lung cancer (170)
Manufacturing (177)
Medical device (13326)
Medtech (13331)
Mergers & acquisitions (19321)
Metabolic disorders (409)
Neuroscience (1518)
NextGen Class of 2024 (6617)
Non-profit (4657)
Northern California (1483)
Obesity (236)
Opinion (193)
Patents (102)
People (57318)
Phase I (20095)
Phase II (28554)
Phase III (21249)
Pipeline (456)
Postmarket research (2595)
Preclinical (8626)
Radiopharmaceuticals (239)
Rare diseases (220)
Real estate (5967)
Regulatory (22035)
Research institute (2380)
Resumes & cover letters (380)
Southern California (1305)
Startups (3627)
United States (13527)
Vaccines (576)
Weight loss (174)
Date
Today (120)
Last 7 days (824)
Last 30 days (3823)
Last 365 days (35920)
2024 (32930)
2023 (40450)
2022 (51646)
2021 (56287)
2020 (54958)
2019 (47579)
2018 (35879)
2017 (32643)
2016 (32201)
2015 (38219)
2014 (31934)
2013 (26952)
2012 (29118)
2011 (29823)
2010 (27803)
Location
Africa (755)
Arizona (193)
Asia (37953)
Australia (6223)
California (3333)
Canada (1289)
China (248)
Colorado (145)
Connecticut (153)
Europe (82424)
Florida (458)
Georgia (119)
Illinois (349)
Indiana (200)
Kansas (96)
Maryland (595)
Massachusetts (2610)
Michigan (158)
Minnesota (275)
New Jersey (957)
New York (958)
North Carolina (707)
Northern California (1483)
Ohio (139)
Pennsylvania (843)
South America (1127)
Southern California (1305)
Texas (464)
Utah (90)
Washington State (359)
697,196 Results for "biocentury publications inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
Biotech Beach
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock - June 14, 2024
Avidity Biosciences, Inc. announced the pricing of an underwritten public offering of 10,550,000 shares of its common stock at a price to the public of $38.00 per share.
June 13, 2024
·
5 min read
BioMidwest
Oragenics, Inc. Announces Closing of Public Offering - June 26, 2024
Oragenics, Inc., a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced the closing of its public offering of 1,100,000 shares of its common stock at an offering price of $1.00 per share.
June 26, 2024
·
3 min read
Press Releases
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
October 29, 2024
·
4 min read
Press Releases
BioVie Inc. Announces Closing of Public Offering
September 26, 2024
·
4 min read
Press Releases
BioVie Inc. Announces Proposed Public Offering
September 24, 2024
·
5 min read
Press Releases
BioVie Inc. Announces Pricing of Public Offering
September 24, 2024
·
5 min read
Press Releases
CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering
October 11, 2024
·
2 min read
Press Releases
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
November 12, 2024
·
5 min read
Press Releases
Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders
October 31, 2024
·
3 min read
1 of 69,720
Next
